Personalized treatment recommendation systems have become a major focus of modern healthcare informatics because conventional clinical decision-making often relies on generalized treatment guidelines that cannot adequately accommodate individual patient heterogeneity. Variations in demographic characteristics, disease progression, genetic predisposition, comorbidities, treatment adherence, and longitudinal clinical responses necessitate intelligent decision-support systems capable of recommending adaptive therapeutic interventions. Reinforcement Learning (RL), a branch of artificial intelligence that learns optimal sequential decision policies through interactions with an environment, has emerged as a promising computational paradigm for personalized medicine. Unlike traditional predictive models that estimate clinical outcomes independently, RL continuously evaluates treatment consequences over time and identifies strategies that maximize cumulative patient benefit while minimizing adverse events.
The growing availability of electronic health records, observational clinical databases, standardized healthcare data models, and real-world evidence has accelerated research on RL-driven treatment optimization. However, practical implementation remains constrained by data quality, privacy protection, observational bias, model interpretability, and clinical acceptance. Furthermore, translating algorithmic recommendations into trustworthy medical decisions requires robust governance, transparent validation, and integration with established healthcare workflows.
This research and review article critically examines reinforcement learning for personalized treatment recommendation systems by synthesizing contemporary literature on health informatics, observational healthcare databases, technology acceptance, and clinical decision support. The study develops an integrated analytical framework connecting reinforcement learning methodologies with real-world healthcare infrastructures and technology adoption theories. Special attention is given to standardized observational data repositories, electronic health record integration, physician acceptance of intelligent decision-support technologies, cybersecurity considerations, and regulatory requirements. The analysis demonstrates that successful implementation depends not only on algorithmic performance but also on healthcare data quality, clinician trust, system usability, regulatory compliance, and secure digital infrastructure. The paper concludes by identifying current research limitations and proposing future directions toward clinically reliable, explainable, and patient-centered reinforcement learning systems capable of supporting precision medicine.